User profiles for Wael Saber
 | Wael SaberMedical College of Wisconsin Verified email at mcw.edu Cited by 14160 |
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
…, JD Rizzo, MM Horowitz, W Saber - Blood, The Journal …, 2014 - ashpublications.org
Because the outcome of allogeneic hematopoietic cell transplantation (HCT) is predominantly
influenced by disease type and status, it is essential to be able to stratify patients …
influenced by disease type and status, it is essential to be able to stratify patients …
[HTML][HTML] Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation
Background Genetic mutations drive the pathogenesis of the myelodysplastic syndrome (MDS)
and are closely associated with clinical phenotype. Therefore, genetic mutations may …
and are closely associated with clinical phenotype. Therefore, genetic mutations may …
[HTML][HTML] Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation
Approximately 20,000 hematopoietic cell transplantation (HCT) procedures are performed
in the United States annually. With advances in transplantation technology and supportive …
in the United States annually. With advances in transplantation technology and supportive …
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
Single-center studies have reported an association between early (before day 100) cytomegalovirus
(CMV) reactivation and decreased incidence of relapse for acute myeloid leukemia (…
(CMV) reactivation and decreased incidence of relapse for acute myeloid leukemia (…
[HTML][HTML] Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant …
…, ID Lewis, Y Atsuta, RF Olsson, W Saber… - Biology of Blood and …, 2015 - Elsevier
Although transplant practices have changed over the last decades, no information is available
on trends in incidence and outcome of chronic graft-versus-host disease (cGVHD) over …
on trends in incidence and outcome of chronic graft-versus-host disease (cGVHD) over …
[HTML][HTML] Current use of and trends in hematopoietic cell transplantation in the United States
…, RA Phelan, ML Riches, JD Rizzo, W Saber… - Biology of Blood and …, 2020 - Elsevier
Hematopoietic cell transplantation (HCT) is a well-established treatment to control and/or
cure many malignant and nonmalignant diseases involving the hematopoietic system and …
cure many malignant and nonmalignant diseases involving the hematopoietic system and …
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel
…, L Volin, HJ Deeg, C Cutler, W Saber… - Blood, The Journal …, 2017 - ashpublications.org
An international expert panel, active within the European Society for Blood and Marrow
Transplantation, European LeukemiaNet, Blood and Marrow Transplant Clinical Trial Group, and …
Transplantation, European LeukemiaNet, Blood and Marrow Transplant Clinical Trial Group, and …
Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia
W Saber, S Opie, JD Rizzo, MJ Zhang… - Blood, The Journal …, 2012 - ashpublications.org
Approximately one-third of patients with an indication for hematopoietic cell transplantation (HCT)
have an HLA-matched related donor (MRD) available to them. For the remaining …
have an HLA-matched related donor (MRD) available to them. For the remaining …
Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation
We examined current outcomes of unrelated donor allogeneic hematopoietic cell transplantation
(HCT) to determine the clinical implications of donor-recipient HLA matching. Adult and …
(HCT) to determine the clinical implications of donor-recipient HLA matching. Adult and …
[HTML][HTML] One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family …
…, MBC Koh, M Aljurf, H Greinix, Y Atsuta, W Saber - …, 2022 - ncbi.nlm.nih.gov
The Worldwide Network of Blood and Marrow Transplantation (WBMT) pursues the mission
of promoting hematopoietic cell transplantation (HCT) for instance by evaluating activities …
of promoting hematopoietic cell transplantation (HCT) for instance by evaluating activities …